(Q48369347)

11 February 2018

http://europepmc.org/abstract/MED/17107596

title

Characterization of glioblastomas in young adults (English)

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

author name string

B K Kleinschmidt-DeMasters

1

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

Lynne Meltesen

2

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

Loris McGavran

3

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

Kevin O Lillehei

4

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

publication date

1 October 2006

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

published in

Brain Pathology

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

volume

16

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

issue

4

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

page(s)

273-286

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

cites work

p53 protein in pediatric malignant astrocytomas: a study of 21 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Primary and secondary glioblastomas: from concept to clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Neoplasms involving the central nervous system in the older old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Proliferation index is related to patient age in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Expression of p53 and prognosis in children with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Long-term survival in patients with supratentorial glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Which glioblastoma multiforme patient will become a long-term survivor? A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

"Turcot's syndrome": phenotype of brain tumors, survival and mode of inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.00029.X

10.1111/J.1750-3639.2006.00029.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

http://europepmc.org/abstract/MED/17107596

1 reference

11 February 2018